Tepotinib is a targeted therapy medication primarily used in the treatment of certain types of non-small cell lung cancer (NSCLC). It is classified as a MET inhibitor, which means it specifically targets and blocks the activity of the MET protein, a receptor that can promote cancer cell growth when mutated or overexpressed. By inhibiting this protein, Tepotinib helps to slow down or stop the progression of cancer in patients with specific genetic mutations.
Teplizumab is a monoclonal antibody that has been developed to help manage autoimmune conditions, particularly Type 1 diabetes. It works by modulating the immune system to prevent the destruction of insulin-producing beta cells in the pancreas. Approved by the FDA in November 2022 as Tzield, Teplizumab represents a significant advancement in delaying Stage 3 Type 1 diabetes, especially for individuals at high risk of developing the disease.
Tenofovir Disoproxil Fumarate (TDF) is an antiviral medication primarily used to treat HIV (Human Immunodeficiency Virus) and chronic hepatitis B infections. It belongs to a class of drugs known as nucleotide reverse transcriptase inhibitors (NRTIs). TDF works by inhibiting the reverse transcriptase enzyme, which is crucial for the replication of the virus. By doing so, it helps to lower the viral load in the body, allowing the immune system to function more effectively.
Tenofovir alafenamide (TAF) is an antiviral medication primarily used to treat chronic hepatitis B and HIV (human immunodeficiency virus) infections. It belongs to a class of drugs known as nucleotide analogue reverse transcriptase inhibitors (NtRTIs or NRTIs). TAF is a prodrug of tenofovir, which means it is converted into its active form in the body. This medication is known for its effectiveness in suppressing viral replication, thereby helping to manage these chronic infections and improve the quality of life for those affected.
Teniposide is a chemotherapy medication primarily used in the treatment of certain types of cancer, primarily for pediatric use. It belongs to a class of drugs known as podophyllotoxins, which are derived from the mandrake plant. Teniposide works by interfering with the process of cell division, ultimately leading to the death of cancer cells. It is often used in combination with other chemotherapy agents to enhance its effectiveness.
Teniposide is primarily approved for the treatment of:
Teneligliptin is an oral medication primarily used to manage type 2 diabetes mellitus. It belongs to a class of drugs known as DPP4 inhibitors (dipeptidyl peptidase-4 (DPP-4) inhibitors), which help control blood sugar levels. By enhancing the body?s natural ability to lower blood sugar, Teneligliptin plays a crucial role in diabetes management, particularly when diet and exercise alone are insufficient.
Tenecteplase is a medication primarily used in the treatment of acute myocardial infarction, commonly known as a heart attack. It is a thrombolytic agent, which means it helps dissolve blood clots that block blood flow to the heart. By restoring blood flow, Tenecteplase can help minimize heart damage and improve outcomes for patients experiencing a heart attack.
Tenecteplase is mainly approved for the following medical uses:
Tenapanor is a medication primarily used to treat certain gastrointestinal conditions, particularly irritable bowel syndrome with constipation (IBS-C) in adults. It is classified as a sodium/hydrogen exchanger 3 (NHE3) inhibitor, which means it works by affecting the transport of sodium and water in the intestines. This action helps to increase the amount of fluid in the intestines, making it easier for patients to have bowel movements.
Temsirolimus is a medication primarily used in the treatment of certain types of cancer, particularly renal cell carcinoma (kidney cancer). It belongs to a class of drugs known as mTOR inhibitors, which work by interfering with the growth and spread of cancer cells. Temsirolimus is administered through injection and is often prescribed when other treatments have not been effective.
Temozolomide is an oral chemotherapy medication primarily used to treat certain types of brain tumors, particularly glioblastoma multiforme and anaplastic astrocytoma. It is classified as an alkylating agent, which means it works by damaging the DNA of cancer cells, preventing them from dividing and growing. Temozolomide is often prescribed when other treatments have failed or in conjunction with radiotherapy to enhance its effectiveness.
Temozolomide is approved for several medical uses, including:
